Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melike Ozcelik

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Medical Oncology (Northwood, London, England)|January 10, 2015
Single-agent bevacizumab is an effective treatment in recurrent glioblastomaIlhan Hacibekiroglu, Hilmi Kodaz, Bulent Erdogan, et al.
Medicina (Kaunas, Lithuania)|August 26, 2023
The Prognostic Utility of the Metastatic Lymph Node Ratio and the Number of Regional Lymph Nodes Removed from Patients with Small Bowel AdenocarcinomasDincer Aydin, Umut Kefeli, Melike Ozcelik, et al.
Irish Journal of Medical Science|August 30, 2019
Clinical outcomes of patients with pure small cell carcinoma of the urinary bladderGokmen Umut Erdem, Mutlu Dogan, Aydin Aytekin, et al.
Future Oncology (London, England)|February 18, 2021
Association of illness perception with chemotherapy-induced nausea and vomiting: a Turkish Oncology Group (TOG) studyTulay Kus, Gokmen Aktas, Melike Ozcelik, et al.
Pharmacotherapy|March 19, 2026
Outcomes of CDK4/6 Inhibitor-Based Therapy in Premenopausal HR+/HER2- Metastatic Breast Cancer: Real World Data From A Multicenter StudyHatice Odabaş, Omar Alomari, Seval Orman, et al.
Current Medical Research and Opinion|November 8, 2016
Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective studyNebi Serkan Demirci, Sercan Aksoy, Nuriye Yıldırım Özdemir, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 13, 2016
Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patientsMelike Ozcelik, Taner Korkmaz, Hatice Odabas, et al.
Current Problems in Cancer|August 15, 2018
Retrospective evaluation of patients diagnosed solid pseudopapillary neoplasms of the pancreasOzlem Ercelep, Nuriye Ozdemir, Nedim Turan, et al.
Clinical Colorectal Cancer|June 2, 2016
Evaluation of Bevacizumab in Advanced Small Bowel AdenocarcinomaDincer Aydin, Mehmet Ali Sendur, Umut Kefeli, et al.
International Journal of Cancer|July 14, 2020
Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controlsIzzet Mehmet Akcay, Elifnaz Celik, Nihat Bugra Agaoglu, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Medical Oncology (Northwood, London, England)|January 10, 2015
Single-agent bevacizumab is an effective treatment in recurrent glioblastomaIlhan Hacibekiroglu, Hilmi Kodaz, Bulent Erdogan, et al.
Medicina (Kaunas, Lithuania)|August 26, 2023
The Prognostic Utility of the Metastatic Lymph Node Ratio and the Number of Regional Lymph Nodes Removed from Patients with Small Bowel AdenocarcinomasDincer Aydin, Umut Kefeli, Melike Ozcelik, et al.
Irish Journal of Medical Science|August 30, 2019
Clinical outcomes of patients with pure small cell carcinoma of the urinary bladderGokmen Umut Erdem, Mutlu Dogan, Aydin Aytekin, et al.
Future Oncology (London, England)|February 18, 2021
Association of illness perception with chemotherapy-induced nausea and vomiting: a Turkish Oncology Group (TOG) studyTulay Kus, Gokmen Aktas, Melike Ozcelik, et al.
Pharmacotherapy|March 19, 2026
Outcomes of CDK4/6 Inhibitor-Based Therapy in Premenopausal HR+/HER2- Metastatic Breast Cancer: Real World Data From A Multicenter StudyHatice Odabaş, Omar Alomari, Seval Orman, et al.
Current Medical Research and Opinion|November 8, 2016
Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective studyNebi Serkan Demirci, Sercan Aksoy, Nuriye Yıldırım Özdemir, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 13, 2016
Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patientsMelike Ozcelik, Taner Korkmaz, Hatice Odabas, et al.
Current Problems in Cancer|August 15, 2018
Retrospective evaluation of patients diagnosed solid pseudopapillary neoplasms of the pancreasOzlem Ercelep, Nuriye Ozdemir, Nedim Turan, et al.
Clinical Colorectal Cancer|June 2, 2016
Evaluation of Bevacizumab in Advanced Small Bowel AdenocarcinomaDincer Aydin, Mehmet Ali Sendur, Umut Kefeli, et al.
International Journal of Cancer|July 14, 2020
Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controlsIzzet Mehmet Akcay, Elifnaz Celik, Nihat Bugra Agaoglu, et al.
Pageof 4